-
Mashup Score: 1Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix - Aziyo - 3 year(s) ago
SILVER SPRING, Md., June 07, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO) on June 2, 2021 issued a voluntary recall pertaining to a single donor lot of its FiberCel Fiber Viable Bone Matrix, a bone repair product made from human tissue that is used in various orthopedic and spinal procedures. Notice of the […]
Source: AziyoCategories: Infectious Disease, Latest HeadlinesTweet
9/ MCQ answer: #Mycobacterium #tuberculosis Patients who used same lot of the implicated FiberCel product should be treated. Healthcare personnel surveillance is recommended if exposed. Product has been recalled by the company. https://t.co/E9U4ipZxSE